Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,479,060
  • Shares Outstanding, K 179,625
  • Annual Sales, $ 1,491 M
  • Annual Income, $ -77,210 K
  • 60-Month Beta 1.30
  • Price/Sales 9.10
  • Price/Cash Flow 353.05
  • Price/Book 4.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.03
  • Number of Estimates 7
  • High Estimate 0.07
  • Low Estimate -0.04
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +110.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.10 +11.83%
on 10/23/19
76.86 -2.37%
on 11/12/19
+6.53 (+9.53%)
since 10/15/19
3-Month
62.88 +19.34%
on 10/02/19
78.74 -4.70%
on 08/21/19
+3.31 (+4.61%)
since 08/15/19
52-Week
62.88 +19.34%
on 10/02/19
100.13 -25.06%
on 02/05/19
-19.71 (-20.80%)
since 11/15/18

Most Recent Stories

More News
Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) updated the investment community on the Company's research and development portfolio, which is focused on innovative therapies to treat rare diseases.

BMRN : 75.04 (-0.71%)
BioMarin Announces Cumulative Additional Height Gain of 9.0 cm over 54 months versus Natural History in Children with Achondroplasia Treated with Vosoritide in Phase 2 Study

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) provided an update on its clinical program for vosoritide, an analog of C-type Natriuretic Peptide (CNP), in children with achondroplasia, the most common form...

BMRN : 75.04 (-0.71%)
Biomarin Pharmac Has Returned 9.3% Since SmarTrend Recommendation (BMRN)

SmarTrend identified an Uptrend for Biomarin Pharmac (NASDAQ:BMRN) on October 24th, 2019 at $69.90. In approximately 3 weeks, Biomarin Pharmac has returned 9.26% as of today's recent price of $76.37.

BMRN : 75.04 (-0.71%)
REGN or BMRN: Which Is the Better Value Stock Right Now?

REGN vs. BMRN: Which Stock Is the Better Value Option?

REGN : 344.87 (+1.91%)
BMRN : 75.04 (-0.71%)
BioMarin to Participate in Jefferies London Healthcare Conference on November 21, 2019

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at the Jefferies London Healthcare Conference on November 21,...

BMRN : 75.04 (-0.71%)
Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates

Sarepta (SRPT) reports wider year-over-year loss. However, revenues increase year over year.

SRPT : 97.46 (+0.05%)
BMRN : 75.04 (-0.71%)
ALKS : 21.00 (+5.37%)
VRTX : 209.80 (+2.34%)
BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an R&D Day at 8:00am ET on Thursday, November 14, 2019. BioMarin management and external experts will provide an update to the investment community...

BMRN : 75.04 (-0.71%)
Watch for Biomarin Pharmac to Potentially Pullback After Gaining 10.54% Yesterday

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $73.70 to a high of $74.90. Yesterday, the shares gained 10.5%, which took the trading range above the 3-day high...

BMRN : 75.04 (-0.71%)
Can The Uptrend Continue for BioMarin Pharmaceutical?

As of late, it has definitely been a great time to be an investor BioMarin Pharmaceutical.

BMRN : 75.04 (-0.71%)
Incyte Corp has the Best Relative Performance in the Biotechnology Industry (INCY , BMRN , ALKS , VRTX , AMGN )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ALKS : 21.00 (+5.37%)
BMRN : 75.04 (-0.71%)
INCY : 86.70 (+1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft.

See More Share

Trade BMRN with:

Business Summary

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment...

See More

Key Turning Points

2nd Resistance Point 76.75
1st Resistance Point 75.90
Last Price 75.04
1st Support Level 74.29
2nd Support Level 73.53

See More

52-Week High 100.13
Fibonacci 61.8% 85.90
Fibonacci 50% 81.50
Fibonacci 38.2% 77.11
Last Price 75.04
52-Week Low 62.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar